KIMBERLY JOHNSON: Open Payments
NPI 1598280984 · DECATUR, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$490 in 18 payments from 7 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $490
Food & beverage: $406Education: $84
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 2 | $111 |
| ABBVIE INC. | 5 | $102 |
| Madrigal Pharmaceuticals | 2 | $94 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $58 |
| Gilead Sciences, Inc. | 2 | $51 |
| Ardelyx, Inc. | 2 | $41 |
| Phathom Pharmaceuticals, Inc. | 2 | $33 |
Products named: TREMFYA, REZDIFFRA, LINZESS, ENTYVIO, IBSRELA, VOQUEZNA, CREON.
Industry payments across AL — which companies pay providers there.
